Aynur Isik (Aynur Isık)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Epstein Barr Virus

Low Density Lipoprotein

Emergency Department

Top Venues

International journal of surgical pathology

Nature communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Meral Uner, Aynur Isik, Sıdıka Oztop, Erdem Karabulut, Seçil Demirkol Canlı, Aytekin Akyol
Gastric Carcinoma with Lymphoid Stroma: A Combination of Mismatch Repair Deficient Medullary Type and Epstein-Barr Virus-associated Gastric Carcinomas. International journal of surgical pathology 30 (6) (2022)
Ozge Akbulut-Caliskan, Deniz Lengerli, Ozge Saatci, Elif Duman, Urartu Özgür Şafak Şeker, Aynur Isik, Aytekin Akyol, Burcu Caliskan, Erden Banoglu, Özgür Sahin
A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate. Molecular cancer therapeutics 19 (6) (2020)
Ozge Saatci, Aysegul Kaymak, Umar Raza, Pelin Gulizar Ersan, Ozge Akbulut-Caliskan, Carolyn E Banister, Vitali Sikirzhytski, Unal Metin Tokat, Zaliha Gamze Aykut, Suhail A Ansari, Hayriye Tatli Dogan, Mehmet Dogan, Pouria Jandaghi, Aynur Isik, Fatma Gündoğdu, Kemal Kosemehmetoglu, Omer Dizdar, Sercan Aksoy, Aytekin Akyol, Aysegül Uner, Phillip J Buckhaults, Yasser Riazalhosseini, Özgür Sahin
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nature communications 11 (1) (2020)